Tuesday, the Senate Finance Committee is scheduled to hold its confirmation hearing for Alex Azar to run the U.S. Department of Health and Human Services. Azar is widely expected to win Senate approval, despite some misgivings over the rise of drug prices while he served as a top executive at drugmaker Eli Lilly. However, it appears Azar will break from previous HHS Secretary Tom Price in one key way.

Click the audio player above to hear the full story.